GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile
Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease
Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer
CMX001 Reduces Adenovirus Progression and Viremia
Biomarker Identified Predicting Graft-Versus-Host Disease Risk
Follow-up Finds Finasteride Reduces Prostate Cancer Risk Without Affecting Lifespan
Study Shows Early Treatment Of Asymptomatic Myeloma Can Improve Survival
Pretreatment with Azacitidine Achieves 28-Month Remission
Specific Pathology Pattern Can Predict Recurrence
20% of Women Do Not Believe Tailored Risk Assessments
Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer
Study Finds Gene Expression Test Predicts Stage I or II Recurrence
NCI CTEP Approved Trials For the Month of August
FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma
Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- White House announces “TrumpRx,” a new prescription drug website
- Pulitzer-winning healthcare reporter Laurie McGinley on her shift to advocacy work with PACR
- U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs - ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
